Company: VRCA
Filing Date: 2025-04-30
Form Type: DEFR14A
Source: 0001193125-25-105562
Chunk: 61

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-04-30
Form: DEFR14A
Chunk 61
---
 | ) |     |                      | 1,061,427 |
| 2023 |     |                                                         |         — |     |                                                                  | —          |   |     |                                                                |         — |     |                                                                                         | — |     |                                                                    | — |     |                                                                                                                   | — |     |                                                                                           | — |     |                                     | —        |   |     |                      |         — |
| 2022 |     |                                                         |         — |     |                                                                  | —          |   |     |                                                                |         — |     |                                                                                         | — |     |                                                                    | — |     |                                                                                                                   | — |     |                                                                                           | — |     |                                     | —        |   |     |                      |         — |

| (5) | The dollar amounts reported represent the average of the amounts reported for the NEOs as a group (excluding the PEO) in the “Total” column of the Summary Compensation Table in each applicable year. The NEOs (excluding the PEO) included for purposes of calculating the average amounts are, Christopher Hayes, Joe Bonaccorso and Gary Goldenberg for 2024, Christopher Hayes and Joe Bonaccorso for 2023 and Gary Goldenberg and Joe Bonaccorso for 2022. |

| (6) | The dollar amounts reported in this column represent the average amount of “compensation actually paid” to the NEOs as a group (excluding the PEO), as computed in accordance with Item 402(v) ofRegulation S-K.In accordance with the requirements of Item 402(v) of RegulationS-K,the following adjustments were made to average total compensation for the NEOs as a group (excluding the PEO) for each year to determine the compensation actually paid. |

| Year |     | TotalCompensationfrom SummaryCompensationTable total($) |           |     | Adjustment forGrant DateValues in theSummaryCompensationTable($) |            |   |     | Year-EndFair ValueofUnvestedAwardsGranted inthe CurrentYear($) |           |     | Year-over-YearDifferenceof Year-EndFairValues forUnvestedAwardsGranted inPrior Years($) |          |   |     | Fair Valuesat VestDate forAwardsGrantedand Vestedin CurrentYear($) |         |     | Difference inFair Valuesbetween PriorYear-End FairValues andVest-Date fairValues forAwardsGranted inPrior Years($) |          |   |     | Prioryear-endfair